DSM-Firmenich AG

BMV:DSM N Rapporto sulle azioni

Cap. di mercato: Mex$14.4b

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

DSM-Firmenich Performance dei guadagni passati

Il passato criteri di controllo 1/6

DSM-Firmenich's earnings have been declining at an average annual rate of -20.7%, while the Chemicals industry saw earnings growing at 20.5% annually. Revenues have been declining at an average rate of 0.8% per year. DSM-Firmenich's return on equity is 4.4%, and it has net margins of 5.4%.

Informazioni chiave

-20.7%

Tasso di crescita degli utili

-20.2%

Tasso di crescita dell'EPS

Chemicals Crescita del settore13.1%
Tasso di crescita dei ricavi-0.8%
Rendimento del capitale proprio4.4%
Margine netto5.4%
Prossimo aggiornamento sui guadagni02 Aug 2023

Aggiornamenti sulle prestazioni recenti

Recent updates

Ripartizione dei ricavi e delle spese

Come DSM-Firmenich guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.

Storia dei guadagni e delle entrate

BMV:DSM N Ricavi, spese e utili (EUR Millions )
DataRicaviGuadagniSpese G+ASpese di R&S
31 Dec 228,3904541,772295
30 Sep 229,582837895162
30 Jun 229,8021,0821,789323
31 Mar 229,5031,0811,789323
31 Dec 217,2698201,649274
30 Sep 217,9556602,517560
30 Jun 217,5584931,622398
31 Mar 217,5724231,622398
31 Dec 208,1064481,622398
30 Sep 207,9605101,639295
30 Jun 208,0345571,639295
31 Mar 209,0117221,795349
31 Dec 197,9986751,639295
30 Sep 198,2728201,839348
30 Jun 198,5027941,839348
31 Mar 199,1249341,839348
31 Dec 189,2671,0691,839348
30 Sep 189,2359841,753334
30 Jun 189,1062,0821,753334
31 Mar 188,9081,9421,753334
31 Dec 178,6321,7611,753334
30 Sep 178,4711,6761,694309
30 Jun 178,3337381,694309
31 Mar 178,1667111,694309
31 Dec 167,9206451,694309
30 Sep 167,8315881,605332
30 Jun 167,7782741,605332
31 Mar 167,7492141,605332
31 Dec 157,7221741,605332
30 Sep 157,607661,382304
30 Jun 157,4561141,382304
31 Mar 157,2451151,382304
31 Dec 147,0511231,382304
30 Sep 147,4151121,430340
30 Jun 147,8341381,430340
31 Mar 148,3621821,430340
31 Dec 138,8582521,430340
30 Sep 138,4093631,396372
30 Jun 138,5003351,396372
31 Mar 138,4862571,396372
31 Dec 128,5882801,396372
30 Sep 129,0894531,356378
30 Jun 129,1075431,356378

Guadagni di qualità: DSM N has high quality earnings.

Margine di profitto in crescita: DSM N's current net profit margins (5.4%) are lower than last year (11.3%).

Flusso di cassa libero e analisi degli utili

Analisi della crescita degli utili nel passato

Andamento degli utili: DSM N's earnings have declined by 20.7% per year over the past 5 years.

Accelerare la crescita: DSM N's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Guadagni vs Settore: DSM N had negative earnings growth (-44.6%) over the past year, making it difficult to compare to the Chemicals industry average (-12.7%).

Rendimento del capitale proprio

ROE elevato: DSM N's Return on Equity (4.4%) is considered low.

Rendimento delle attività

Rendimento del capitale investito

Scoprire le aziende con forti performance passate

7D

1Y

7D

1Y

7D

1Y